Table 5 Multivariate outcome analysis by cox regression, overall survival
HPV DNA negative | HPV DNA positive | p value | Overall survivala | ||
|---|---|---|---|---|---|
HR (95%Cl) | p value | ||||
CDKN2A | |||||
Negative (n = 72) | 55 (76%) | 17 (24%) | 0.003 | 0.30 (0.073–1.263) | 0.10 |
Positive (n = 12) | 3 (25%) | 9 (75%) | |||
TP53 | |||||
Negative (n = 56) | 37 (66%) | 19 (34%) | 0.06 | 1.38 (0.75–2.52) | 0.30 |
Positive (n = 28) | 21 (75%) | 7 (25%) | |||
EGFR | |||||
Negative (n = 73) | 49 (66%) | 24 (33%) | 0.54 | 1.03 (0.49–2.16) | 0.94 |
Positive (n = 11) | 9 (85%) | 2 (15%) | |||
CD274 | |||||
Negative (n = 62) | 41 (66%) | 21 (34%) | 0.43 | 1.15 (0.57–2.32) | 0.70 |
Positive (n = 21) | 16 (76%) | 5 (24%) | |||
